Thursday, April 15, 2004 3:50:35 PM
Ginchinchili@aol.com writes:
> (Didn't know whether to email this to you or go through the "contact us" on
> your website, so I did both.)
>
> Dear Dr. Moskowitz:
> I try not to bother you with inane questions because I know your time is
> valuable. Hopefully, you won't consider this inane. Here in Mississippi I've been
> contacting newspapers, TV stations, the governor, my congressman, and,
> finally, the State Health Dept. about your West Nile Virus Clinical Trial. The doctor
> I talked with at the State Health Dept. was aware of the case of West Nile
> Virus in Ohio where your protocol was used with great success. She told me that
> they have the protocol on file and that doctors treating WNV have access to
> that protocol. She could describe it well enough to where I knew it was yours.
> My question is this, did you and/or Paul Knopick contact the state health
> depts. sharing with them your protocol? This would make sense to me to promote the
> clinical trial. Since I know Mississippi has it on file, is any doctor here
> who utilizes your treatment protocol required to report back to you so that you
> may log the info in the interests of the trial results? Am I even in the right
> ballpark here? I'm just trying to figure out how this is shaping up and,
> also, wanted to make sure that you were aware that Mississippi has your protocol
> on file. Thanks...James Kelley
Dear Mr. Kelley,
Thanks for all your legwork.
I contacted all 50 State Depts of Health last summer (and got nowhere), and
again in early March this year. So they got a chance to see our protocol
twice.
What would be ideal is if the State Depts of Health didn't avoid clinical
interventional trials like the plague, and actually helped publicize our
protocol to physicians and patients in the state, rather than just keep it
in a file. Fat lot of good it does anybody locked away in a file drawer.
They wouldn't have to lift a finger. All they'd have to do is mention our
website on their WNV page, or, better yet, provide a link to our home page.
It could be as simple as that. But I haven't found a single Dept of Health
willing to do that. Something about staying away from all clinical trials...
With this attitude, there's no way polio would have been beaten. It was the
public health authorities that led the charge in 1954. Now, they're an
infinite sink of energy and good will, a black hole where people go for help
and get none, even when help is readily available.
Yours,
Dave Moskowitz MD
****************************************
David W. Moskowitz, MD, MA (Oxon.), FACP
Chairman, CEO and Chief Medical Officer
GenoMed, Inc.
website: www.genomedics.com
ticker symbol: GMED (on OTC Pinksheets)
Address:
909 S. Taylor Ave.
St. Louis, MO 63110
tel. 314-977-0115
FAX 314-754-9772
cell phone 314-378-7864
email: dwmoskowitz@genomedics.com
Recent GMED News
- Globus Medical Launches the Next Wave of Orthopedic Trauma Solutions • GlobeNewswire Inc. • 10/02/2024 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 08:34:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 08:31:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/13/2024 08:03:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/13/2024 07:55:06 PM
- Globus Medical Launches ADIRA™ XLIF™ Plate System • GlobeNewswire Inc. • 08/21/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 09:10:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:20:25 PM
- Globus Medical Reports Second Quarter 2024 Results • GlobeNewswire Inc. • 08/06/2024 08:15:00 PM
- Globus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System • GlobeNewswire Inc. • 07/17/2024 12:30:00 PM
- Globus Medical Schedules Second Quarter Earnings Release and Conference Call • GlobeNewswire Inc. • 07/16/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 08:25:27 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/11/2024 03:07:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 08:15:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 09:16:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 08:48:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/10/2024 08:15:52 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/10/2024 04:11:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/08/2024 08:11:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/08/2024 07:59:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:21:08 PM
- Globus Medical Reports First Quarter 2024 Results • GlobeNewswire Inc. • 05/07/2024 08:15:00 PM
- Globus Medical Schedules First Quarter Earnings Release and Conference Call • GlobeNewswire Inc. • 04/16/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:07:51 PM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • Oct 10, 2024 8:09 AM
FEATURED CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM